In the early stage of CHF, lnc-NOS2P3 is lowly expressed to release miR-939-5p, which controls the target genes iNOS and TNFα as well as NO synthesis during New York Heart Association Class (NYHA) I-II phase, thereby inhibiting myocardial and ERS apoptosis. Here, NOS2P3 is linked to congestive heart failure.